戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 odestructive invadosome-forming phenotype of synovial cells.
2 rticular chondrocytes and in fibroblast-like synovial cells.
3 ecruitment of EPCs and hyperproliferation of synovial cells.
4 spontaneous release of cytokines by human RA synovial cells.
5 iate adherence to respiratory epithelial and synovial cells.
6 pulmonary artery endothelial cells and human synovial cells.
7 adherence to both respiratory epithelial and synovial cells.
8 with catabolic processes in chondrocytes and synovial cells.
9 popolysaccharide and in rheumatoid arthritis synovial cells.
10  expression and apoptosis are evident in the synovial cells.
11 uired for the prodestructive phenotype of RA synovial cells.
12 arkedly increase aFGF production by cultured synovial cells.
13 tion of calcium from intracellular stores in synovial cells.
14 require elimination of most or all activated synovial cells.
15 cells, 55% of the cytokines were produced by synovial cells (39% exclusive to synoviocytes and not ex
16 ilage boundary lubrication and inhibition of synovial cell adhesion.
17 iate adherence to respiratory epithelial and synovial cells and are selected against during invasive
18 ockade led to profound hyperproliferation of synovial cells and arthritogenic lymphocytes and heighte
19                   Pro-Df was present in both synovial cells and chondrocytes of knees of WT and MASP1
20 cible hyaluronan-binding protein produced by synovial cells and chondrocytes that is present in synov
21       Interleukin 1 (IL-1), produced by both synovial cells and chondrocytes, plays a pivotal role in
22 ression of NKG2D and its ligands on human RA synovial cells and extended this finding to the paws of
23 itis are characterized by hyperactivation of synovial cells and hyperplasia of the synovial membrane.
24 stigated by Western blot analysis of primary synovial cells and immunohistochemical analysis of RA jo
25 igh levels of Fas are expressed on activated synovial cells and infiltrating leukocytes in the inflam
26 lites and crystals in the synovium, activate synovial cells and mediate synovial inflammation.
27 rylated VEGFR2 in articular chondrocytes and synovial cells and reduce levels of phosphorylated VEGFR
28 ient adherence to respiratory epithelial and synovial cells and that the number of pili expressed by
29   Of significance, Snail is overexpressed in synovial cells and tissues of CIA rats and RA patients,
30 els of FasL expression, induced apoptosis of synovial cells, and ameliorated collagen-induced arthrit
31 Keystones are inflammation, proliferation of synovial cells, and attachment and invasion of synovial
32 /-) donors and recipients, flow cytometry of synovial cells, and competition experiments measuring en
33                  Mutant glenoid fossa, disc, synovial cells, and condyles displayed higher Hyaluronan
34 rg4) is secreted by surface chondrocytes and synovial cells, and has been shown to reduce friction in
35  in vitro, including monocytes, fibroblasts, synovial cells, and keratinocytes.
36 6), is induced in fibroblasts, chondrocytes, synovial cells, and mononuclear cells by the proinflamma
37 duced the expression of mdm2 by normal human synovial cells approximately 8-fold.
38 ndrocytes, genes for inflammatory factors in synovial cells, as well as pain-related proteins and ion
39 nase activity inhibition in human primary RA synovial cells attenuated gene expressions of inflammato
40 um correlates with the level of adherence to synovial cells but not with the level of adherence to re
41 trate that SAA is synergistically induced in synovial cells by interleukin (IL)-1 and IL-6 that are p
42  induces extracellular matrix degradation in synovial cells by repressing PTEN, resulting in increase
43 RNA variant of ADAMTS4 (ADAMTS4_v1) in human synovial cell cocultures obtained from patients with ost
44             SIGIRR was also overexpressed in synovial cells derived from RA patients.
45 an T cell subpopulations and fibroblast-like synovial cells (FLS) and examine its pathophysiologic si
46 (mRNA) expression in lymph node cells and in synovial cells from arthritic paws was measured by RNase
47 r matrix-degrading invadosomal structures by synovial cells from collagen-induced arthritis (CIA) rat
48 ytes and regulates inflammatory cytokines in synovial cells from human knee joints.
49 FcgammaRII F(ab')2 treatment of inflammatory synovial cells from RA patients inhibited ROS production
50 significantly more pronounced in the primary synovial cells from rheumatoid arthritis patients than t
51 lpha transcripts were clearly evident in the synovial cells from the arthritic paws of IFNgamma-/- mi
52  FGF synthesis and release is a component of synovial cell growth that is markedly increased in RA.
53 he protection of surfaces and the control of synovial cell growth.
54 an and bovine chondrocytes, human and rabbit synovial cells, human epithelial cells, and rodent fibro
55 of functional cardiomyocytes from pathogenic synovial cells in RA patients through iPSC reprogramming
56  in human carcinomas and in chondrocytes and synovial cells in rheumatoid arthritis and osteoarthriti
57 ovial cadherin-11 determines the behavior of synovial cells in their proinflammatory and destructive
58 re used to examine the expression of aFGF by synovial cells in vitro.
59 that could account for the survival of CD95+ synovial cells in vivo.
60 jA (0-30 microM) in vitro to human blood and synovial cells increased production of LXA(4) (ELISA) 2-
61  findings suggest a novel mechanism by which synovial cells induce degradation of cartilage matrix th
62 ibition of synovial angiogenesis and reduced synovial cell infiltrate, pannus formation, and cartilag
63 t the interaction of viable spirochetes with synovial cells leads to the release of IL-8, which proba
64 ression vector was transfected into a rabbit synovial cell line (HIG-82) and a stably transfected cel
65                 Data from a study with SW982 synovial cell line and primary human synoviocytes showed
66 ction of the sIL-1R expression vector into a synovial cell line in vitro resulted in the appearance o
67               Acidic FGF was detected in all synovial cell lines during growth in vitro; however, syn
68 ransfected in vitro, and SV40-transformed RA synovial cell lines in SCID mice were transfected in viv
69 ucible specific inhibitor of apoptosis in RA synovial cell lines.
70 r bone was evident in any section containing synovial cell-loaded ceramic cubes that were harvested a
71                                        These synovial cells may contribute directly to the expansion
72                    Adherent human rheumatoid synovial cells mobilize intracellular calcium via a P2U-
73 -1 protein was immunochemically localized to synovial cells of knees of WT mice with arthritis.
74 arthritis, with increased amounts present in synovial cells of WT mice with CAIA.
75                                The activated synovial cells produce inflammatory cytokines and degrad
76 viously, we showed that iron increased human synovial cell proliferation and induced c-myc expression
77  was dependent on type I IFNs that inhibited synovial cell proliferation and inflammatory cytokine pr
78 in and assigned a histologic score (based on synovial cell proliferation, cartilage erosion, bone ero
79 nonuclear cells from HJD subjects stimulated synovial cell proliferation, which was blocked by a huma
80 emophilic synovitis and a marked increase in synovial cell proliferation.
81 hese cytokines induced phenotypic changes in synovial cells, promoting protrusion and increased cellu
82                    In cocultures, IL-1RII(+) synovial cells released sIL-1RII, which in a paracrine f
83                        One patient developed synovial cell sarcoma 8 years after therapy.
84 , which is expressed in 80% of patients with synovial cell sarcoma and approximately 25% of patients
85 s were observed in four of six patients with synovial cell sarcoma and five of 11 patients with melan
86 ies or a T-cell receptor against NY-ESO-1 in synovial cell sarcoma and melanoma.
87 d tumors, including pediatric neuroblastoma, synovial cell sarcoma, melanoma, and human papillomaviru
88 s gained approvals: 1 for melanoma and 1 for synovial cell sarcoma.
89 ion in patients with metastatic melanoma and synovial cell sarcoma.
90 utic approach for patients with melanoma and synovial cell sarcoma.
91 g 18 months was observed in one patient with synovial cell sarcoma.
92 based prognostic variables characteristic of synovial cell sarcoma.
93 complement regulator can result in prolonged synovial cell surface binding and significant clinical b
94 joints are extremely low, and most activated synovial cells survive despite high levels of Fas expres
95  induce VEC growth directly and to stimulate synovial cells to produce endothelial growth factors.
96 es, human B cells, and human fibroblast-like synovial cells treated with SSRIs.
97 iocytes and 26,192 chondrocytes: 12 distinct synovial cell types and 7 distinct articular chondrocyte
98                      Finally, hyperplasia of synovial cells was associated with increased expression
99                                     Isolated synovial cells were also tested for their chondrogenic p
100                  Both RA and noninflammatory synovial cells were competent to release aFGF into the m
101                                Fura-2-loaded synovial cells were screened for changes in cytosolic ca
102 in lipopolysaccharide-stimulated human SW982 synovial cells were significantly suppressed by silencin
103                                        Human synovial cells, when incubated with HJD sera, could elic
104 a have been well characterized in immune and synovial cells, which are known to be major contributors
105               Synovial explants and isolated synovial cells will undergo chondrogenesis when cultured
106 egulate inflammatory signaling in immune and synovial cells, yet their collective impact on injury-in

 
Page Top